References
- Esquenazi A, Albanese A, Chancellor MB, et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. Toxicon. 2013;67:115–128.
- Doan QV, Brashear A, Gillard PJ, et al. Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity. Pm R. 2012;4:4–10.
- Welmer AK, von Arbin M, Widen Holmqvist L, et al. Spasticity and its association with functioning and health-related quality of life 18 months after stroke. Cerebrovasc Dis. 2006;21:247–253.
- Sakel M, Mackenzie R. Patient satisfaction with botulinum txin therapy in adult spasticity. Int J Ther Rehabil. 2009;16:280–288.
- Mahoney JS, Engebretson JC, Cook KF, et al. Spasticity experience domains in persons with spinal cord injury. Arch Phys Med Rehabil. 2007;88:287–294.
- Bensmail D, Hanschmann A, Wissel J. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians). J Med Econ. 2014;17:618–625.
- Carr AJ, Gibson B, Robinson PG. Measuring quality of life: is quality of life determined by expectations or experience? BMJ. 2001;322:1240–1243.
- Rathert C, Wyrwich MD, Boren SA. Patient-centered care and outcomes: a systematic review of the literature. Med Care Res Rev. 2013;70:351–379.
- Collins LG, Swartz K. Caregiver care. Am Fam Physician. 2011;83:1309–1317.
- Viana MC, Gruber MJ, Shahly V, et al. Family burden related to mental and physical disorders in the world: results from the WHO World Mental Health (WMH) surveys. Rev Bras Psiquiatr. 2013;35:115–125.
- Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation: a practical guide. Clin Rehabil. 2009;23:362–370.
- Turner-Stokes L, Williams H, Johnson J. Goal attainment scaling: does it provide added value as a person-centred measure for evaluation of outcome in neurorehabilitation following acquired brain injury? J Rehabil Med. 2009;41:528–535.
- Turner-Stokes L, Fheodoroff K, Jacinto J, et al. Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice. BMJ Open. 2013;3:e002230.
- Ward AB, Wissel J, Borg J, et al. BEST Study Group. Functional goal achievement in post-stroke spasticity patients: the BOTOX® Economic Spasticity Trial (BEST). J Rehabil Med. 2014;46:504–513.
- Schoeb V, Staffoni L, Parry R, et al. “What do you expect from physiotherapy?”: a detailed analysis of goal setting in physiotherapy. Disabil Rehabil. 2014;36:1679–1686.
- Bhimani RH, McAlpine CP, Henly SJ. Understanding spasticity from patients' perspectives over time. J Adv Nurs. 2012;68:2504–2514.
- McMullan M. Patients using the Internet to obtain health information: how this affects the patient-health professional relationship. Patient Educ Couns. 2006;63:24–28.
- Royal College of Physicians (UK). Spasticity in adults: management using botulinum toxin. UK: Royal College of Physicians; 2009.
- Wissel J, Ward AB, Erztgaard P, et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med. 2009;41:13–25.
- Tao W, Yan D, Li JH, et al. Gait improvement by low-dose botulinum toxin A injection treatment of the lower limbs in subacute stroke patients. J Phys Ther Sci. 2015;27:759–762.
- Rosales RL, Kong KH, Goh KJ, et al. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Neurorehabil Neural Repair. 2012;26:812–821.
- Fietzek UM, Kossmehl P, Schelosky L, et al. Early botulinum toxin treatment for spastic pes equinovarus – a randomized double-blind placebo-controlled study. Eur J Neurol. 2014;21:1089–1095.